SPRY vs TSM
ARS Pharmaceuticals, Inc (SPRY) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
TSM (TSM) common stock.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
TSM does not have a complete income-statement cache yet.
SPRY currently screens at market cap $983.1M. TSM currently screens at market cap $0.
Not investment advice. Open the SPRY and TSM stock pages for the full models.
Not investment advice.